Product NDC: | 42291-892 |
Proprietary Name: | Venlafaxine Hydrochloride |
Non Proprietary Name: | Venlafaxine Hydrochloride |
Active Ingredient(s): | 25 mg/1 & nbsp; Venlafaxine Hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 42291-892 |
Labeler Name: | AvKARE, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA079098 |
Marketing Category: | ANDA |
Start Marketing Date: | 20120507 |
Package NDC: | 42291-892-90 |
Package Description: | 90 TABLET in 1 BOTTLE (42291-892-90) |
NDC Code | 42291-892-90 |
Proprietary Name | Venlafaxine Hydrochloride |
Package Description | 90 TABLET in 1 BOTTLE (42291-892-90) |
Product NDC | 42291-892 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Venlafaxine Hydrochloride |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20120507 |
Marketing Category Name | ANDA |
Labeler Name | AvKARE, Inc. |
Substance Name | VENLAFAXINE HYDROCHLORIDE |
Strength Number | 25 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Norepinephrine Uptake Inhibitors [MoA],Serotonin and Norepinephrine Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA] |